Medical Management of Kidney Stones
Publication Date: July 31, 2014
Last Updated: March 14, 2022
Guideline Statements
Evaluation
A clinician should perform a screening evaluation consisting of a detailed medical and dietary history, serum chemistries and urinalysis on a patient newly diagnosed with kidney or ureteral stones. (Clinical Principle)
322859
Clinicians should obtain serum intact parathyroid hormone level as part of the screening evaluation if primary hyperparathyroidism is suspected. (Clinical Principle)
322859
When a stone is available, clinicians should obtain a stone analysis at least once. (Clinical Principle)
322859
Clinicians should obtain or review available imaging studies to quantify stone burden.
322859
Clinicians should perform additional metabolic testing in high-risk or interested first-time stone formers and recurrent stone formers. (Strong, B)
322859
Metabolic testing should consist of one or two 24-hour urine collections obtained on a random diet and analyzed at minimum for total volume, pH, calcium, oxalate, uric acid, citrate, sodium, potassium and creatinine. (Expert Opinion)
322859
Clinicians should not routinely perform “fast and calcium load” testing to distinguish among types of hypercalciuria. (Moderate, C)
322859
Title
Medical Management of Kidney Stones
Authoring Organization
American Urological Association